{"id":5835,"date":"2022-06-30T11:49:33","date_gmt":"2022-06-30T09:49:33","guid":{"rendered":"https:\/\/ekarpen.es\/?p=5835"},"modified":"2022-09-28T09:11:10","modified_gmt":"2022-09-28T07:11:10","slug":"5835","status":"publish","type":"post","link":"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/","title":{"rendered":""},"content":{"rendered":"<h1><strong><a href=\"https:\/\/www.elcorreo.com\/sociedad\/ciencia\/cura-cancer-pancreas-laboratorio-vasco-abre-puerta-posible-cura-20220523135827-nt.html\" target=\"_blank\" rel=\"noopener\">Un laboratorio vasco abre una nueva v\u00eda para la curaci\u00f3n del c\u00e1ncer<\/a><\/strong><\/h1>\n<h3><strong>La terapia contra el tumor pancre\u00e1tico dise\u00f1ada por Oncomatryx act\u00faa por primera vez contra las c\u00e9lulas que lo rodean y cuenta con un enorme potencial para curar enfermedades metast\u00e1sicas de pulm\u00f3n y mama, entre otros \u00f3rganos.<\/h3>\n<p><\/strong><\/p>\n<p>Lunes, 23 Mayo 2022<\/p>\n<p align=\"justify\">Un laboratorio vasco ha dise\u00f1ado una nueva terapia contra tumores s\u00f3lidos, llamada a revolucionar por completo el tratamiento contra el c\u00e1ncer. El f\u00e1rmaco de la compa\u00f1\u00eda Oncomatryx act\u00faa por primera vez no contra las c\u00e9lulas tumorales, como han venido funcionando los tratamientos convencionales, sino contra las que rodean la lesi\u00f3n, algo que los cient\u00edficos denominan microambiente tumoral y que tiene la capacidad de expandir la enfermedad por el organismo. El preparado, que comienza a probarse en pacientes a partir del pr\u00f3ximo mes de junio, ha obtenido en experimentaci\u00f3n celular y con animales unos resultados nunca vistos hasta la fecha, tan buenos e inesperados que han sorprendido incluso a los cient\u00edficos que trabajan en el ensayo.<\/p>\n<p align=\"justify\">Cuando comenz\u00f3 la investigaci\u00f3n, hace quince a\u00f1os, el laboratorio vasco trabajaba con la idea de dise\u00f1ar la primera terapia realmente eficaz frente al c\u00e1ncer de p\u00e1ncreas, que es uno de los m\u00e1s mortales. S\u00f3lo entre el 1% y el 4% de los pacientes logra sobrevivir m\u00e1s all\u00e1 de los cinco a\u00f1os despu\u00e9s del diagn\u00f3stico. El prototipo dise\u00f1ado por Oncomatryx, bautizado a\u00fan con el nombre &#8216;OMTX705&#8217;, ha demostrado durante la investigaci\u00f3n ser mucho mejor de lo que sus creadores imaginaban. La nueva formulaci\u00f3n, en cuyo dise\u00f1o han participado prestigiosos hospitales y universidades de Europa y Estados Unidos, ha mostrado un enorme potencial no s\u00f3lo para frenar el avance de la enfermedad, sino incluso para curar otras neoplasias malignas del pulm\u00f3n y la mama, entre otros \u00f3rganos.<\/p>\n<p align=\"justify\"><strong>Ocho hospitales de Europa y Estados Unidos<\/strong><\/p>\n<p align=\"justify\">El medicamento comenzar\u00e1 a probarse el pr\u00f3ximo mes de junio en 150 pacientes de ocho hospitales, siete de ellos espa\u00f1oles, entre los que figura uno vasco, el Onkologikoa de San Sebasti\u00e1n, donde se recibir\u00e1n voluntarios de toda la comunidad aut\u00f3noma vasca. El octavo es el Beth Israel Hospital de la Universidad de Harvard, que liderar\u00e1 los ensayos cl\u00ednicos en Estados Unidos. El grupo se completa con los hospitales Val D`Hebron e Instituto Catal\u00e1n de Oncolog\u00eda (ICO), en Catalu\u00f1a; el Doce de Octubre y el MB Anderson Cancer Center, en Madrid; el Virgen de la Victoria, en M\u00e1laga; y la Cl\u00ednica Universidad de Navarra (CUN), en Pamplona.<\/p>\n<p align=\"justify\">La larga lista de grandes instituciones internacionales que colaboran en este proyecto avala la enorme esperanza depositada en \u00e9l. La relaci\u00f3n incluye a prestigiosas universidades, hospitales y centros de investigaci\u00f3n de ambos lados del Atl\u00e1ntico. Entre ellos, figuran la Universidad de Stuttgart; la de Turin; otro centro vasco de renombre internacional, que es el CIC BioGune; el Centro Nacional de Investigaciones Oncol\u00f3gicas (CNIO), Onkologikoa, la Universidad de Harvard y el MC Anderson Cancer Center.<\/p>\n<p align=\"justify\"><strong>En cinco a\u00f1os<\/strong><\/p>\n<p align=\"justify\">Las palabras pronunciadas por el consejero delegado de Oncomatryx, el investigador Laureano Sim\u00f3n, en la rueda de prensa de presentaci\u00f3n esta ma\u00f1ana del comienzo de la fase de experimentaci\u00f3n en humanos del ensayo evidencian la enorme esperanza que la comunidad cient\u00edfica internacional ha depositado en \u00e9l. \u00abEstamos abriendo una nueva v\u00eda de atacar el c\u00e1ncer metast\u00e1sico, tan eficaz que nos hace creer firmemente en la posibilidad de que podremos curar mucha enfermedad provocada por tumores s\u00f3lidos. \u00bfEs demasiado optimista pensar en algo as\u00ed? Quiz\u00e1s, pero estamos convencidos de que estamos trabajando con lo que en unos a\u00f1os ser\u00e1 una parte importante del tratamiento que el onc\u00f3logo podr\u00e1 ofrecer a su paciente\u00bb, ha afirmado.<\/p>\n<p align=\"justify\">Las agencias del medicamento de Estados Unidos (FDA) y la espa\u00f1ola (AEMPS), perteneciente a la red de agencias de Europa (EMA), est\u00e1n preparadas para agilizar la autorizaci\u00f3n del f\u00e1rmaco en caso de que las pruebas en humanos repitan los resultados obtenidos con animales. Oncomatryx conf\u00eda en que, si esto es as\u00ed, &#8216;OMTX705&#8217; entre a formar parte del arsenal terap\u00e9utico contra el c\u00e1ncer en el plazo de cinco a\u00f1os.<\/p>\n","protected":false},"excerpt":{"rendered":"<div class=\"slide-text-bg2\"><span>Un laboratorio vasco abre una nueva v\u00eda para la curaci\u00f3n del c\u00e1ncer La terapia contra el tumor pancre\u00e1tico dise\u00f1ada por Oncomatryx act\u00faa por primera <\/span><\/div>\n<div class=\"slide-btn-area-sm\"><a href=\"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/\" class=\"slide-btn-sm\">Leer m\u00e1s<\/a><\/div>\n","protected":false},"author":1,"featured_media":5845,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,2,3],"tags":[],"class_list":["post-5835","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-slider-eu","category-slider","category-slider-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.10 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>- Ekarpen<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"- Ekarpen\" \/>\n<meta property=\"og:description\" content=\"Un laboratorio vasco abre una nueva v\u00eda para la curaci\u00f3n del c\u00e1ncer La terapia contra el tumor pancre\u00e1tico dise\u00f1ada por Oncomatryx act\u00faa por primera Leer m\u00e1s\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/\" \/>\n<meta property=\"og:site_name\" content=\"Ekarpen\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-30T09:49:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-28T07:11:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ekarpen.es\/wp-content\/uploads\/2022\/06\/cura-cancer-pancreas-kr0B-RSELRBICTbaOlKBkhcnswTK-624x385@El-Correo-ElCorreo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"624\" \/>\n\t<meta property=\"og:image:height\" content=\"385\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/ekarpen.es\/#\/schema\/person\/862a5840b47598403adafb98da7acd93\"},\"headline\":\"Sin t\u00edtulo\",\"datePublished\":\"2022-06-30T09:49:33+00:00\",\"dateModified\":\"2022-09-28T07:11:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/\"},\"wordCount\":736,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ekarpen.es\/#organization\"},\"articleSection\":[\"[:es]slider[:]\",\"[:es]slider[:]\",\"[:es]slider[:]\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/\",\"url\":\"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/\",\"name\":\"- Ekarpen\",\"isPartOf\":{\"@id\":\"https:\/\/ekarpen.es\/#website\"},\"datePublished\":\"2022-06-30T09:49:33+00:00\",\"dateModified\":\"2022-09-28T07:11:10+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ekarpen.es\/#website\",\"url\":\"https:\/\/ekarpen.es\/\",\"name\":\"Ekarpen\",\"description\":\"Ayuda a la consolidaci\u00f3n y dinamizaci\u00f3n del tejido industrial vasco.\",\"publisher\":{\"@id\":\"https:\/\/ekarpen.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ekarpen.es\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ekarpen.es\/#organization\",\"name\":\"Ekarpen\",\"url\":\"https:\/\/ekarpen.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/ekarpen.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ekarpen.es\/wp-content\/uploads\/2021\/11\/cropped-cropped-logo_arriba-1-3-e1635925388252.jpg\",\"contentUrl\":\"https:\/\/ekarpen.es\/wp-content\/uploads\/2021\/11\/cropped-cropped-logo_arriba-1-3-e1635925388252.jpg\",\"width\":200,\"height\":50,\"caption\":\"Ekarpen\"},\"image\":{\"@id\":\"https:\/\/ekarpen.es\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ekarpen.es\/#\/schema\/person\/862a5840b47598403adafb98da7acd93\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/ekarpen.es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/def358d3e74880c7e18de1b2929721c1f9a100fc32dff1be76d409131853cd6e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/def358d3e74880c7e18de1b2929721c1f9a100fc32dff1be76d409131853cd6e?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/ekarpen.es\"],\"url\":\"https:\/\/ekarpen.es\/index.php\/author\/agomez_tu2jy8l1\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"- Ekarpen","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/","og_locale":"es_ES","og_type":"article","og_title":"- Ekarpen","og_description":"Un laboratorio vasco abre una nueva v\u00eda para la curaci\u00f3n del c\u00e1ncer La terapia contra el tumor pancre\u00e1tico dise\u00f1ada por Oncomatryx act\u00faa por primera Leer m\u00e1s","og_url":"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/","og_site_name":"Ekarpen","article_published_time":"2022-06-30T09:49:33+00:00","article_modified_time":"2022-09-28T07:11:10+00:00","og_image":[{"width":624,"height":385,"url":"https:\/\/ekarpen.es\/wp-content\/uploads\/2022\/06\/cura-cancer-pancreas-kr0B-RSELRBICTbaOlKBkhcnswTK-624x385@El-Correo-ElCorreo.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/#article","isPartOf":{"@id":"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/"},"author":{"name":"admin","@id":"https:\/\/ekarpen.es\/#\/schema\/person\/862a5840b47598403adafb98da7acd93"},"headline":"Sin t\u00edtulo","datePublished":"2022-06-30T09:49:33+00:00","dateModified":"2022-09-28T07:11:10+00:00","mainEntityOfPage":{"@id":"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/"},"wordCount":736,"commentCount":0,"publisher":{"@id":"https:\/\/ekarpen.es\/#organization"},"articleSection":["[:es]slider[:]","[:es]slider[:]","[:es]slider[:]"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/","url":"https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/","name":"- Ekarpen","isPartOf":{"@id":"https:\/\/ekarpen.es\/#website"},"datePublished":"2022-06-30T09:49:33+00:00","dateModified":"2022-09-28T07:11:10+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ekarpen.es\/index.php\/2022\/06\/30\/5835\/"]}]},{"@type":"WebSite","@id":"https:\/\/ekarpen.es\/#website","url":"https:\/\/ekarpen.es\/","name":"Ekarpen","description":"Ayuda a la consolidaci\u00f3n y dinamizaci\u00f3n del tejido industrial vasco.","publisher":{"@id":"https:\/\/ekarpen.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ekarpen.es\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ekarpen.es\/#organization","name":"Ekarpen","url":"https:\/\/ekarpen.es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ekarpen.es\/#\/schema\/logo\/image\/","url":"https:\/\/ekarpen.es\/wp-content\/uploads\/2021\/11\/cropped-cropped-logo_arriba-1-3-e1635925388252.jpg","contentUrl":"https:\/\/ekarpen.es\/wp-content\/uploads\/2021\/11\/cropped-cropped-logo_arriba-1-3-e1635925388252.jpg","width":200,"height":50,"caption":"Ekarpen"},"image":{"@id":"https:\/\/ekarpen.es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ekarpen.es\/#\/schema\/person\/862a5840b47598403adafb98da7acd93","name":"admin","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ekarpen.es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/def358d3e74880c7e18de1b2929721c1f9a100fc32dff1be76d409131853cd6e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/def358d3e74880c7e18de1b2929721c1f9a100fc32dff1be76d409131853cd6e?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/ekarpen.es"],"url":"https:\/\/ekarpen.es\/index.php\/author\/agomez_tu2jy8l1\/"}]}},"_links":{"self":[{"href":"https:\/\/ekarpen.es\/index.php\/wp-json\/wp\/v2\/posts\/5835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ekarpen.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ekarpen.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ekarpen.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ekarpen.es\/index.php\/wp-json\/wp\/v2\/comments?post=5835"}],"version-history":[{"count":4,"href":"https:\/\/ekarpen.es\/index.php\/wp-json\/wp\/v2\/posts\/5835\/revisions"}],"predecessor-version":[{"id":5844,"href":"https:\/\/ekarpen.es\/index.php\/wp-json\/wp\/v2\/posts\/5835\/revisions\/5844"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ekarpen.es\/index.php\/wp-json\/wp\/v2\/media\/5845"}],"wp:attachment":[{"href":"https:\/\/ekarpen.es\/index.php\/wp-json\/wp\/v2\/media?parent=5835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ekarpen.es\/index.php\/wp-json\/wp\/v2\/categories?post=5835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ekarpen.es\/index.php\/wp-json\/wp\/v2\/tags?post=5835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}